Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi

Exclusion Criteria

• •either chronic aspergillosis, aspergilloma, or ABPA
• •Advanced HIV infection with CD4 count \< 200 or acquired immunodeficiency syndrome-defining condition
• •people who are unlikely to survive 5 days or participants on mechanical ventilation
• •severe hepatic impairment (Child-Pugh Class C)
• •familial short QT syndrome
• •Concomitant use of efavirenz, ritonavir, etravirine, rifampicin/rifampin, rifabutin, nafcillin, ketoconazole, or St. John's Wort in the 5 days prior to first administration of study intervention